ExLibris header image
SFX Logo
Title: Differential cardiovascular effects of propranolol, atenolol, and pindolol measured by impedance cardiography
Source:

European Journal of Clinical Pharmacology [0031-6970] Thomas, S. H. L. yr:1992


Collapse list of basic services Basic
Full text
Full text available via SpringerLINK Contemporary 1997-Present
GO
Full text available via SpringerLink Historical Archives Biomedical and Life Sciences
GO
Document delivery
Request document via Library/Bibliothek GO
Users interested in this article also expressed an interest in the following:
1. Lilleberg, J M M. "Hemodynamic effects of the novel cardiotonic drug simendan: echocardiographic assessment in healthy volunteers." Cardiovascular drugs and therapy 8.2 (1994): 263-9. Link to Full Text for this item Link to SFX for this item
2. Vapaatalo, H. "Divergent effects of atenolol, practolol and propranolol on the peripheral metabolic changes induced by dynamic exercise in healthy men." European journal of clinical pharmacology 25.3 (1983): 293-7. Link to Full Text for this item Link to SFX for this item
3. Ioannis, Lefkos S. "Effects of atenolol and pindolol on left ventricular structure and function in hypertensive patients." American journal of hypertension 14.4, Supplement 1 (2001). Link to SFX for this item
4. Lammers, J W. "Ventilatory effects of atenolol and bevantolol in asthma." Clinical pharmacology & therapeutics 38.4 (1985): 428-33. Link to SFX for this item
5. Fodor, J. "A comparison of the side effects of atenolol and propranolol in the treatment of patients with hypertension." The Journal of clinical pharmacology 27.11 (1987): 892-901. Link to SFX for this item
6. Darga, Nicholaus L. "Comparison of the effects of guanadrel sulfate and propranolol on blood pressure, functional capacity, serum lipoproteins and glucose in systemic hypertension." The American journal of cardiology 64.5 (1991): 590-596. Link to Full Text for this item Link to SFX for this item
7. Carter, J. "COMPARATIVE CHRONOTROPIC ACTIVITY OF BETA-ADRENOCEPTIVE ANTAGONISTS." British Journal of Pharmacology 40.3 (1970): 373-381. Link to Full Text for this item Link to SFX for this item
8. Roberts, D.. "Placebo-controlled comparison of captopril, atenolol, labetalol, and pindolol in hypertension complicated by intermittent claudication." The lancet 330.8560 (1987): 650-3. Link to SFX for this item
9. Head, A. "Exercise metabolism and beta-blocker therapy. An update." Sports medicine 27.2 (1999): 81-96. Link to SFX for this item
10. Garcia, JAP P. "Levosimendan in acute decompensation of anthracycline-induced cardiotoxicity." International Journal of Cardiology 118.3 (2007): 406-407. Link to SFX for this item
11. Verhaegen, J. "Comparison of the subacute hemodynamic effects of atenolol, propranolol, pindolol, and nebivolol." Angiology 41.2 (1990): 95-105. Link to Full Text for this item Link to SFX for this item
12. Gugler, R. "Double-blind comparison of once-daily bopindolol, pindolol and atenolol in essential hypertension." European journal of clinical pharmacology 27.5 (1984): 529-34. Link to Full Text for this item Link to SFX for this item
13. Tong, L. "Bioequivalence of montelukast sodium dispersible tablets in human body." yao xue fu wu yu yan jiu 10.5 (2010): 371-373. Link to SFX for this item
14. Abrahamsen, A M M. "Comparison of the side-effects of pindolol and atenolol in the treatment of hypertension." Journal of internal medicine 228.3 (1990): 219-22. Link to SFX for this item
15. Mebazaa, A. "Levosimendan vs dobutamine for patients with acute decompensated heart failure: the SURVIVE Randomized Trial." JAMA 297.17 (2007): 1883-1891. Link to SFX for this item
16. Sarawate, Mark J A. "Achievement of optimal combined lipid values in a managed care setting: Is a new treatment paradigm needed?" Clinical therapeutics 29.1 (2007): 196-209. Link to SFX for this item
17. FOERSTER, E. "ATENOLOL VERSUS PINDOLOL - SIDE-EFFECTS IN HYPERTENSION." European Journal of Clinical Pharmacology 28.1 (1985): 89-91. Link to Full Text for this item Link to SFX for this item
18. Erikssen, J. "Comparison of beta-adrenoceptor blockers under maximal exercise (pindolol v metoprolol v atenolol)." British journal of clinical pharmacology 13.Suppl 2 (1982): 201-209. Link to Full Text for this item Link to SFX for this item
19. Gugler, R. "The effect of pindolol on exercise-induced cardiac acceleration in relation to plasma levels in man." Clinical pharmacology & therapeutics : CPT. 17.2: 127-133. Link to SFX for this item
20. Sedgwick, P. "Standard deviation or the standard error of the mean." BMJ. British medical journal 350.feb17 1 (2015). Link to SFX for this item
View More...
View Less...
Select All Clear All

Expand list of advanced services Advanced